Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 16Active not recruiting 4Not yet recruiting 2Completed 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Pyruvate Kinase Deficiency of Red Cells 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Melanoma 1Leukemia, Myeloid, Acute 1Diabetes Mellitus, Insulin-Dependent, 12 1Anemia, Hemolytic, Congenital 1

Interventions

pembrolizumab 17Carboplatin 13Paclitaxel 12Cisplatin 12Radiation 10Doxorubicin 10Cyclophosphamide 9Radiotherapy 8Vincristine 7Nivolumab 7Metformin 7Etoposide 7Cytarabine 7Radiotherapy, Intensity-Modulated 6Magnetic Resonance Spectroscopy 6Leucovorin 6Injections 6Fluorouracil 6tislelizumab 5Prednisone 5Pemetrexed 5Methotrexate 5Ipilimumab 5Cetuximab 5Bevacizumab 5fludarabine 4durvalumab 4atezolizumab 4Specimen Handling 4Radiotherapy, Conformal 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Blood Specimen Collection × 30 days × Clear all
NCT04253080 2026-05-20

ENZYMELA

Assistance Publique - Hôpitaux de Paris

Phase NA Completed
127 enrolled
Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma

NCT04902833 2026-05-19

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Massachusetts General Hospital

Completed
18 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Pyruvate Kinase Deficiency of Red Cells, Anemia, Hemolytic, Congenital, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡